The first Biocept trade was made in Q2 2021.
Since then Ken Griffin bought shares three more times and sold shares on five occasions. The investor completely sold their stake between Q1 2023 and Q2 2023.
Avg closing price
Price range
Sold -273 shares
Q2 2023
Avg closing price
$1.39
Price range
$0.21
-
$6.65
Sold 20.9% shares (-72 shares)
Q1 2023
Avg closing price
$0.48
Price range
$0.24
-
$0.62
New holding (+346 shares)
Q4 2022
Avg closing price
$0.74
Price range
$0.47
-
$0.93
Sold -1.61 Thousand shares
Q3 2022
Avg closing price
$0.99
Price range
$0.75
-
$1.20
Increased shares by 153.2% (+971 shares)
Q2 2022
Avg closing price
$1.52
Price range
$0.88
-
$2.27
Sold 66.0% shares (-1.23 Thousand shares)
Q1 2022
Avg closing price
$2.62
Price range
$1.83
-
$3.97
Increased shares by 241.0% (+1.32 Thousand shares)
Q4 2021